Ophthalmic Diseases and AI: an RCT Study

计划入组 2,000 人 · 首次发布于 2025 年 9 月 4 日

Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases

计划入组 170 人 · 首次发布于 2024 年 1 月 11 日

Multi-modal Intelligent Diagnosis System for Multiple Ophthalmic Diseases

计划入组 5,000 人 · 首次发布于 2025 年 8 月 27 日

Ophthalmic diseases(Spotlight)

Allergy-related diseases(FunPep)

Ophthalmic disease(NanoCarrier)

Alzheimer's Disease And Related Disorders Association, Inc.

United States

Implandata Ophthalmic Products GmbH

Germany

Ziemer Ophthalmic Systems AG

Switzerland

Oculis Advances Novel Therapies for Ophthalmic Diseases with Promising Pipeline Development

Samsung Bioepis' OfubizTM (Aflibercept) Biosimilar Approved in Europe for Ophthalmic Diseases

Lifecore Biomedical Secures Two New CDMO Agreements, Including Fourth Commercial Site Transfer in Five Months